ArticleCancers2022

A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition.

Ananya Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.